Phage therapy shows promise for combating antibiotic resistance, highlighting the need for collaboration and clinical trials.
Although phage therapy offers a promising complement to existing antimicrobials, routine clinical implementation requires harmonized regulatory pathways, scalable production standards, and rigorously designed clinical trials. Strategic international collaboration and integration of emerging technologies will be pivotal in advancing phage therapy toward sustainable clinical adoption.
No takes yet. Share an insight, caveat, or question.
Bhale et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: